Omeicos Therapeutics attracts Series A funds
Berlin, Germany-based Omeicos Therapeutics, a biopharmaceutical company focused on preventing and treating cardiovascular diseases, has secured 6.2 million euros in Series A funding. The investors included Vesalius Biocapital, VC Fonds Technologie Berlin, Hightech Gruenderfonds and KfW Group.
17 April 2015•6 mins read
